A detailed history of Seven Mile Advisory transactions in Zoetis Inc. stock. As of the latest transaction made, Seven Mile Advisory holds 1,234 shares of ZTS stock, worth $204,251. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,234
Previous 1,180 4.58%
Holding current value
$204,251
Previous $205 Million 17.86%
% of portfolio
0.16%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $9,319 - $10,609
54 Added 4.58%
1,234 $241 Million
Q2 2024

Aug 08, 2024

SELL
$145.54 - $178.83 $5,676 - $6,974
-39 Reduced 3.2%
1,180 $205 Million
Q1 2024

May 08, 2024

BUY
$165.67 - $199.94 $14,578 - $17,594
88 Added 7.78%
1,219 $206 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $171,278 - $226,301
1,131 New
1,131 $223 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.